OpenAI launches academic initiative to expand access to GPT-Rosalind for life sciences research

OpenAI has launched the Rosalind Academic Plan, offering eligible university labs free access to GPT-Rosalind, a specialized life sciences model, for up to 12 months. The initiative provides up to 30 Business Standard seats at no cost, with access subject to trusted-access approval. The plan aims to accelerate scientific discovery by enabling researchers to combine their expertise with AI tools tailored for life sciences. GPT-Rosalind supports complex biological reasoning and is designed for applications in medicinal chemistry, genomics, and other scientific domains. The program is currently available to U.S. university labs, with eligibility based on institutional and researcher credentials. OpenAI emphasizes the importance of academic research in driving medical and biotechnological advancements, highlighting historical breakthroughs like the Human Genome Project and CRISPR-Cas9. The initiative also includes guidelines for responsible use and safety checks to ensure ethical research practices. The Rosalind Academic Plan allows researchers to explore applications such as drug design, disease diagnostics, and genetic therapy development. Access is granted through a trusted-access process, with PIs and lab leads managing permissions and ensuring compliance. The program excludes API access and focuses on fostering collaboration between scientists and AI tools to address global health and food security challenges. OpenAI underscores its commitment to supporting foundational research that can lead to transformative medical and scientific outcomes.